Vaccinex, Inc. (VCNX): Shareholders' Equity

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$2.49M
As of 2024-12-31
$15.34M2017-12-31: -$113.49M2018-12-31: $15.34M2019-12-31: -$2.27M2020-12-31: -$2.61M2021-12-31: $7.41M2022-12-31: $5.19M2023-12-31: -$2.31M2024-12-31: -$2.49M-$2.49M
2017-12-31 Shareholders' Equity (USD) 2024-12-31
Period endedShareholders' EquityChange YoYSource filing
2024-12-31-$2.49Mn/m2025-04-15, Balance as of period end
2023-12-31-$2.31Mn/m2025-04-15, Balance as of period end
2022-12-31$5.19M-29.9%2024-04-25, Balance as of period end
2021-12-31$7.41Mn/m2023-03-31, Balance as of period end
2020-12-31-$2.61Mn/m2022-03-31, Balance as of period end
2019-12-31-$2.27Mn/m2021-03-31, Balance as of period end
2018-12-31$15.34Mn/m2020-03-09, Balance as of period end
2017-12-31-$113.49Mn/a2019-03-13, Balance as of period end